
Loading, please wait...

Loading, please wait...

India records nearly 6 lakh cases of birth anomalies in India annually. Consequently, these congenital conditions now account for a significant share of child deaths. As infectious disease mortality declines, the need for better surveillance grows urgent. Currently, India contributes approximately 16% of global deaths linked to birth defects. This trend highlights a critical gap in the existing healthcare infrastructure.
Congenital heart disease and cleft lip represent a substantial part of the healthcare burden. Furthermore, conditions like spina bifida, Down syndrome, and sensory impairments remain common. Many of these defects are treatable with early detection and intervention. However, multidisciplinary care is rarely integrated into routine newborn services. Therefore, experts emphasize the need for structured long-term care pathways and specialized training for providers.
Smile Train India and the Birth Defects Research Foundation recently launched the Birth Anomalies Network of India (BIND). This multi-stakeholder platform aims to push for prevention and early diagnosis. Additionally, it advocates for a proposed National Birth Anomalies Registry. This registry would generate reliable nationwide data to identify preventable risk factors. Consequently, it would guide health planning and resource allocation more effectively across different states.
Current surveillance remains fragmented and localized across different healthcare facilities. Similarly, screening protocols are often uneven, especially outside major metropolitan areas. Referral pathways for complex surgical cases remain weak in rural sectors. By establishing a national registry, India can finally track these conditions systematically. This initiative will likely improve survival outcomes for thousands of families across the country.
Q1: What is the estimated number of babies born with anomalies in India each year?
Approximately six lakh babies are born with congenital anomalies in India every year, contributing to a significant portion of the global burden of birth defects.
Q2: What is the primary objective of the BIND network?
The Birth Anomalies Network of India (BIND) aims to promote prevention, early diagnosis, and the creation of a national registry for structured long-term care.
Q3: Why is a national registry necessary for birth defects?
A national registry helps generate reliable data, identifies preventable risk factors, and ensures that policy responses are systematic rather than fragmented.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


India reports 6 lakh annual birth anomalies. The new BIND network pushes for a national registry to track congenital conditions and improve pediatric outcom...
7 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today